Decoy Therapeutics Inc. Debt Securities, Available-for-sale
Decoy Therapeutics Inc. (DCOY) had Debt Securities, Available-for-sale of $0 as of 2019-06-30, per its 10-Q filed 2019-07-17.
Discontinued › Balance Sheet › Assets
us-gaap:AvailableForSaleSecuritiesDebtSecurities · last filed 2019-07-17
- 2019-06-30: Debt Securities, Available-for-sale $0.00.
- 2019-03-31: Debt Securities, Available-for-sale $0.00.
- 2018-12-31: Debt Securities, Available-for-sale $0.00.
- 2018-09-30: Debt Securities, Available-for-sale $0.00.
| Period end | Debt Securities, Available-for-sale |
|---|---|
| 2019-06-30 | $0.00 10-Q · filed 2019-07-17 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 |
| 2018-12-31 | $0.00 10-Q · filed 2019-07-17 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-05 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-01 |
| 2017-12-31 | $14.13M 10-K · filed 2019-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |